Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
1(50.0%)
Phase 4
1(50.0%)
2Total
N/A(1)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT01620541Active Not Recruiting

Comparing Ankle Fusion to Ankle Replacement

Role: collaborator

NCT03938467Phase 4Completed

Irrisept C.Acnes Study

Role: lead

NCT03812237Not ApplicableCompleted

Early Weight Bearing Tarsometatarsal Fusion Study

Role: lead

NCT01366872Completed

Agility LP Ankle Arthroplasty Outcomes

Role: lead

All 4 trials loaded